Investor Relations

2019 September | Opal option exercise fuels development plan

2019 August | Opal partners in new ARC Research Hub

2019 July | Opal EOFY Update

2019 Mar | Opal Releases Half Year Results Announcement – 31 Dec 2018

2019 Mar | Opal Half-year Financial Report – 31 Dec 2018


2018 Opal Joins Global Antimicrobial Challenge

2018 Opal AGM CEO Presentation

2018 Opal AGM Results of Meeting

2018 Opal AGM Chairman’s Address

2018 Opal Biosciences 2018 Annual Report

2018 Opal Biosciences Notice of Meeting and Proxy Form


2018 August | Opal New Board Addition

2018 August | Opal Update


2018 July | Opal Information Memorandum Announcement

2018 July | Opal Information Memorandum Document

2018 July | Opal July Presentation


2018 May | BioDiem receives Innovation Connections grant for Opal work


2018 Apr |  Half-year Results

2018 Apr |  Half-year Financial Report – 31 Dec 2017


2018 | Completion of Placement and Board change


2018 | Scedosporium patent grant in US and Europe


2017 Oct | Opal Annual Report


2017 Oct | Notice of Annual General Meeting – Explanatory Statement and Proxy Form


2017 Jul | Company Update and EOFY 2017 Information


2016 Dec | Half-year Financial Report – 31 December 2016


2016 Nov | New European patents for Opal Biosciences antimicrobial BDM-I


2016 Oct | Results of Meeting-Opal Biosciences


2016 Oct | Opal Biosciences Chairman’s Address


2016 | Opal Biosciences Notice of Meeting and proxy form 2016


2016 Jun | OpalBiosciences Annual Report 2016


2015 Aug | Opal Update


2015 Aug | Shareholder Update


2015 Jul | Opal technology presented at the Aust Society for Microbiology Meeting


2015 Jul | Successful grant for BDM-I – Griffith University


2015 Jun | Opal’s anti-infective technology profiled at BIO International Convention, 2015


2015 Jun | Opal Biosciences Update


2015 May | Introducing Opal Biosciences

Send Enquiry

[/text_output]

Contact Us
  • Name*full name
    0
  • Phone*full name
    1
  • Email*a valid email address
    2
  • Comments*something more
    3
  • 4

[/vc_column]

Contact

Opal Biosciences Ltd
ACN 605 631 963

Telephone: + 61 3 9692 7240
Facsimile: + 61 3 9077 9233

Registered Office

Opal Biosciences Ltd
Level 4, 100 Albert Road
South Melbourne
Victoria 3205

[/vc_row]

Leave a Reply

Your email address will not be published. Required fields are marked *